Explore our hospital-grade medical disposables designed for clinical safety, fluid dynamics, and biomaterial longevity. Each device undergoes 100% batch-released EO sterilization and bio-compatibility testing.
In contemporary endourology, the Double J Stent (ureteral stent) plays a vital clinical role in maintaining ureteral patency, mitigating postoperative strictures, facilitating stone fragment passage following extracorporeal shockwave lithotripsy (ESWL) or ureteroscopy (URS), and restoring urinary drainage in obstructive nephropathy.
As a premier original equipment manufacturer (OEM) and supplier exporting directly to Israel, our manufacturing infrastructure combines medical-grade aromatic polyurethane (TPU) and biocompatible silicone formulations. Our stents feature advanced thermo-sensory compliance: maintaining optimal structural rigidity at room ambient temperature for effortless fluoroscopic positioning, and softening dynamically at 37°C intra-body temperature to reduce vesicoureteral reflux (VUR) and trigonal irritation.
Urolithiasis and ureteral obstructions represent significant clinical loads in Mediterranean healthcare environments. Extended indwelling times frequently lead to biofilm formation, bacterial colonization (e.g., Proteus mirabilis), and urinary salt encrustation.
Our engineering team utilizes proprietary fluoropolymer extrusion technologies and ultra-smooth surface finishing protocols. By eliminating microscopic extrusion micro-voids, our Double J Stents significantly diminish bacterial adhesion sites, extending safe indwelling intervals for short-term (up to 30 days) and long-term (up to 365 days) oncology indications.
"Technical Specification Note for Israeli Procurement Directors: All Double J Stent kits supplied to the Israeli market come pre-assembled or co-packaged with PTFE-coated nitinol guidewires, pushers, and radiopaque clamps, meeting Ministry of Health (MOH) AMAR regulatory guidelines."
Israel’s public and private healthcare sectors—anchored by leading Health Maintenance Organizations (HMOs: Clalit, Maccabi, Leumit, and Meuhedet) alongside world-renowned medical centers such as Sheba Medical Center (Tel Hashomer), Hadassah University Medical Center, Rambam Health Care Campus, and Soroka Medical Center—demand uncompromised device performance, tight tolerance specifications, and continuous supply chain reliability.
Due to regional climatic factors in Southern and Central Israel, metabolic kidney stone disease presents at high frequencies. Following Flexible Ureteroscopy (RIRS) or Percutaneous Nephrolithotomy (PCNL), edema at the ureteropelvic junction (UPJ) or ureterovesical junction (UVJ) can impede renal outflow. Our 4.7 Fr to 8.0 Fr Double J Stents provide immediate obstruction relief, facilitating the passage of residual stone dust while preventing renal colic and hydronephrosis.
For patients suffering from retroperitoneal fibrosis, pelvic malignancies, or gynecological tumor compressions causing ureteral strictures, long-term silicone and high-durometer polyurethane Double J Stents offer high circumferential radial strength. They resist extrinsic compression, maintaining patent urine flow from the renal pelvis to the bladder over 6 to 12-month indwelling periods without structural deformation.
In surgical procedures such as pyeloplasty, ureteroureterostomy, and kidney transplants performed in surgical suites across Tel Aviv, Jerusalem, and Haifa, our pediatric and adult Double J Stents (3.0 Fr to 6.0 Fr; 10 cm to 30 cm lengths) serve as critical internal splints. They protect anastomotic lines, promote mucosal healing, and diminish the incidence of urine leaks or postoperative stricture formation.
Recognizing that end-stage renal disease (ESRD) patients frequently present with concurrent urological complications, our manufacturing facilities also supply high-flow tunneled hemodialysis catheters, central venous access kits, and AV fistula accessories. This holistic nephro-urology portfolio enables medical distributors in Israel to streamline their tender sourcing from a single, vertically integrated manufacturer.
The table below highlights the physical, mechanical, and biological benchmarks of our ureteral stent series engineered for high-demand clinical environments.
| Performance Parameter | Our OEM Double J Stent Series | Standard Market Alternatives | Clinical Advantage for Israeli Hospitals |
|---|---|---|---|
| Biomaterial Formulation | Thermosensitive Medical Polyurethane / Pure Silicone | Generic Low-Grade PVC or Hard Polyurethane | Softens at body temperature (37°C), dramatically reducing patient bladder spasms & pain. |
| Coating Coefficient of Friction | Hydrophilic PVP (< 0.02 µ) | Uncoated / Basic Silicone Oil (> 0.15 µ) | Provides effortless placement over guidewires without ureteral mucosal abrasion. |
| Radiopacity Level | 28% Bismuth Subcarbonate Content | 12% - 15% Barium Sulfate | Crystal-clear visibility under low-dose C-arm fluoroscopy, shortening operative exposure time. |
| Coil Retention Force | High Elastic Memory Double Pigtail | Moderate Shape Memory | Prevents stent displacement or upward migration during active physical patient movement. |
| Sterilization Standard | Ethylene Oxide (EO) ISO 11135 Validated | Basic Gamma / Unvalidated EO | Ensures 10⁻⁶ Sterility Assurance Level (SAL) with residual limits far below EU/Israeli MOH caps. |
The Israeli medical device sector operates under strict regulatory oversight administered by the MOH Medical Devices Division (AMAR). Medical importers and hospital procurement teams require fast-track registration access, comprehensive technical dossiers, and absolute compliance with European Union Medical Device Regulation (EU MDR 2017/745) and ISO 13485:2016 standards.
Key market dynamics driving urological purchasing in Israel include:
Operating out of our advanced industrial medical complex since 1988, our enterprise (Shree Umiya Surgical / Mediplus) combines over 36 years of precision polymer processing with complete clean-room vertical integration.
We perform raw material inspection, precision extrusion, tip forming, hole punching, hydrophilic coating deposition, blister packaging, and EO chamber sterilization entirely in-house. This single-source control eliminates quality variations, guarantees lot-to-lot consistency, and enables competitive pricing models for Israeli medical tenders.
Practical answers regarding technical specs, AMAR registration documentation, minimum order quantities (MOQ), and logistical lead times for Israeli ports.
Looking to elevate your urological product portfolio, participate in Israeli HMO tenders, or secure high-margin OEM manufacturing? Contact our global export team today for technical data sheets, sample evaluation kits, and factory-direct quotation pricing.